Prognostic value of troponins in sepsis: a meta-analysis
- 1.9k Downloads
The role of biomarkers such as troponin in risk stratification of sepsis is still debated. The aim of this meta-analysis is to assess the relation between troponin elevation in sepsis and mortality.
All observational studies from Embase, Medline and those manually searched up to September 2010 were included. Studies identified were those which reported on patients with a diagnosis of sepsis and if a 2 × 2 table could be constructed based on troponins and death. We pooled the relative risk (RR) and odds-ratio (OR) using the inverse variance method in studies that conducted univariate and multivariable (adjusted) analysis.
Thirteen studies encompassing 1,227 patients were included. The prevalence of elevated troponin was 61 % ([95 %] CI 58–64 %). Elevated troponin was significantly associated with all-cause mortality (RR 1.91; CI 1.63–2.24), with homogeneity across studies. In adjusted analysis (four studies comprising 791 patients) according to prognostic scores, elevated troponin was associated with an increased risk of death (OR 1.92; CI 1.35–2.74). The area under the ROC curve was 0.68 (CI 0.63–0.71). Pooled sensitivity and specificity were 77 % (CI 61–88) and 47 % (CI 30–64) with heterogeneity across studies. It corresponded to positive and negative likelihood ratios of 1.50 (95 % CI: 1.20–1.90) and 0.49 (CI 0.38–0.64), respectively.
Elevated troponin identifies a subset of patients with sepsis at higher risk of death. Further studies are needed to define the precise role of troponins and their optimal cut-offs.
KeywordsSepsis Prognosis Sensitivity Specificity Meta-analysis
For help with editing in English, and other valuable advice, the authors thank Dr. Michael Cotton of the Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland. We are grateful to FG Brivet for the additional data from his study. Grants, funding, financial support: none declared.
Conflicts of interest
- 4.Khan IA, Tun A, Wattanasauwan N, Win MT, Hla TA, Hussain A, Vasavada BC, Sacchi TJ (1999) Elevation of serum cardiac troponin I in non cardiac and cardiac diseases other than acute coronary syndromes. Am J Emerg Med 17:225–229Google Scholar
- 7.Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB (2000) Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of observational studies in epidemiology (MOOSE) group. JAMA 283:2008–2012CrossRefPubMedGoogle Scholar
- 9.American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis (1992) Crit Care 20:864–874Google Scholar
- 17.STATA. Data analysis and statistical software. Copyright StataCorp. College Station, TXGoogle Scholar
- 38.Altmann DR, Korte W, Maeder MT, Fehr T, Haager P, Rickli H, Kleger GR, Rodriguez R, Ammann P (2010) Elevated cardiac troponin I in sepsis and septic shock: no evidence for thrombus associated myocardial necrosis. PLoS One 5Google Scholar
- 40.Dinnes J, Deeks J, Kirby J, Roderick P (2005) A methodological review of how heterogeneity has been examined in systematic reviews of diagnostic test accuracy. Health Technol Assess 9:1–113Google Scholar